ISIN:CH0042615283

DocMorris continues to grow in the first quarter of 2024 and creates digital access to the entire e-prescription market

Retrieved on: 
Friday, May 3, 2024
Telehealth, OTC, Prescription, Digital, Patient, CHF, Pharmacy, Growth

DocMorris continued the positive revenue trend of the previous quarter as planned in the first quarter of 2024.

Key Points: 
  • DocMorris continued the positive revenue trend of the previous quarter as planned in the first quarter of 2024.
  • External revenue [1] increased by 10.3 per cent in local currency compared to the same period of the previous year.
  • As at the end of March 2024, the number of active customers [2] increased by 600,000 to 9.7 million compared to the previous quarter.
  • TeleClinic, the leading platform for online doctor consultations in Germany, continued to grow very strongly in the first quarter of 2024.

Resolutions of the 31st Annual General Meeting of DocMorris AG of 2 May 2024 in Zurich

Retrieved on: 
Friday, May 3, 2024
Annual, Sustainability, Health, Compensated emancipation, Compensation, Proxy, Zur Rose Group, Patient, CHF, Nomination, Annual report, SIX Swiss Exchange, Management

All members of the Board of Directors and the Nomination and Compensation Committee were confirmed for a further term of office until the next Annual General Meeting.

Key Points: 
  • All members of the Board of Directors and the Nomination and Compensation Committee were confirmed for a further term of office until the next Annual General Meeting.
  • Buis Bürgi AG as independent proxy and Ernst & Young AG as auditors were re-elected.
  • The company was renamed from Zur Rose Group AG to DocMorris AG in May 2023 after the Swiss business was sold to Migros/Medbase.
  • The shares of DocMorris AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker DOCM).

DocMorris setzt Wachstumskurs im ersten Quartal 2024 fort und schafft digitalen Zugang zum gesamten E-Rezept-Markt

Retrieved on: 
Friday, May 3, 2024
DocMorris, Quartal, Prozent, Umsatz, CHF, Anzahl, Kunden, Vergleich, Hauptmarkt, OTC, Arzneimittel, Anfang, Elektronisches Rezept, Indikation, Marktanteil, Trend, Erwartung, Gesundheitskarte, Rollout, Woche, Marktpotenzial, Werktag, Patient, Verordnung, Rahmen, Betreuung, Weiche, Nutzung, Telemedizin, Arztpraxis, Krankengeschichte, Epos, Pflicht, Plattform, Standard, Hintergrund, Investitionsausgaben, Online

DocMorris erzielt signifikantes Umsatzplus im vierten Quartal 2023 und bestätigt Wendepunkt durch Zunahme des aktiven Kundenstamms

Retrieved on: 
Wednesday, January 17, 2024
Wendepunkt, Wachstum, DocMorris, CHF, Prozent, Erwartung, Quartal, Unternehmen, Entwicklung, Hauptmarkt, Treiber, Arzneimittel, OTC, Erholung, RX, Anzahl, Kunden, Vergleich, Arztpraxis, Kategorien, Fertigarzneimittel, Rezept, Nutzung, Einrichtung, Mitte, Gesellschafterversammlung, Gematik, Produkt, Telematikinfrastruktur, Gesundheitskarte, Smartphone, PIN, NEAR, Weg, Rahmen, Patient, Elektronisches Rezept, Management, Ziel, Verbesserung, Investitionsausgaben, Online

DocMorris achieves significant revenue growth in the fourth quarter of 2023 and confirms inflection point by increasing active customer base

Retrieved on: 
Wednesday, January 17, 2024
Patient, Near field, Zur Rose Group, EHealth, NFC, Prescription, OTC, PIN, Pharmacy, CHF, Smartphone, Growth, Cryptocurrency

Inflection point confirmed and basis for sustainable, profitable growth strengthened

Key Points: 
  • Inflection point confirmed and basis for sustainable, profitable growth strengthened
    DocMorris has clearly achieved its revenue target for the full year 2023.
  • In the main market of Germany, external revenue in the fourth quarter rose by 14.7 per cent in local currency compared to the previous year.
  • OTC revenue grew by 18.4 per cent in local currency in the fourth quarter, while Rx revenue declined only slightly by 2.2 per cent in local currency.
  • At the end of 2023, the number of active customers [2] increased by 300,000 to 9.1 million compared to the previous quarter.

DocMorris AG: DocMorris demands fully digital non-discriminatory access to e-prescriptions

Retrieved on: 
Thursday, July 6, 2023
SIX Swiss Exchange, Zur Rose Group, Freedom, Civil service commission, Werner Egk, Pharmacy, European Commission, Federal Ministry of Health (Germany), NFC, PIN, Patient, ISIN, Federal republic, CHF, Conference, Online shopping, Health insurance, EU, Health

[1]

Key Points: 
  • [1]
    “Fully digital, non-discriminatory redemption channels for e-prescriptions are a prerequisite for market access and fair competition for EU-foreign online pharmacies and their patients,” explains Walter Hess, CEO of DocMorris, the importance of the e-prescription for online pharmacies.
  • Until the nationwide mandatory use of the e-prescription from 1 January 2024, DocMorris demands the implementation of a low-threshold user-friendly redemption channel that is also open to online pharmacies.
  • In doing so, DocMorris is pursuing its vision of creating a digital health ecosystem for everyone to manage their health in one click.
  • The shares of DocMorris AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker DOCM).

New stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE)

Retrieved on: 
Thursday, May 11, 2023
SIX Swiss Exchange, Zur Rose Group, Annual, ROSE, Patient, ISIN, Health, Valor, CHF, Conference, Palladium, Health insurance

New stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE)

Key Points: 
  • New stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE)
    New stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE)
    As of today, the ticker symbol for the shares of DocMorris AG – formerly Zur Rose Group AG – traded on the SIX Swiss Exchange is now "DOCM".
  • The Annual General Meeting approved the change of name from Zur Rose Group AG to DocMorris AG on 4 May 2023.
  • The company was renamed from Zur Rose Group AG to DocMorris AG in May 2023 after the Swiss business was sold to Migros/Medbase.
  • The shares of DocMorris AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker DOCM).